Status:

COMPLETED

Special Investigation of Humira® (Adalimumab) on Long-term Treatment in Patients With Rheumatoid Arthritis

Lead Sponsor:

AbbVie (prior sponsor, Abbott)

Conditions:

Rheumatoid Arthritis

Eligibility:

All Genders

15+ years

Brief Summary

The purpose of this study was to collect data on the incidence of adverse drug reactions, infections and malignant tumors, as well as factors that might affect the safety and effectiveness of Humira® ...

Detailed Description

Rheumatoid arthritis is a chronic autoimmune disease which requires long-term treatment. Due to the need of long-term safety data in Japanese participants and to fulfil the conditions of approval of a...

Eligibility Criteria

Inclusion

  • Inclusion criteria:
  • Participants who received adalimumab in accordance with its indications for treatment and dosage regimens.
  • Participants who used adalimumab continuously.
  • Participants without current or past history of malignant tumors.
  • Participants evaluated for Disease Activity Score 28 - 4 Erythrocyte Sedimentation Rate (DAS28-4ESR).
  • Participants evaluated by Health Assessment Questionnaire (HAQ) or Modified Health Assessment Questionnaire (MHAQ) prior to the initiation of adalimumab treatment in the all-case PMOS.
  • Exclusion criteria:
  • Contraindications according to the package insert.
  • Participants with serious infections.
  • Participants with tuberculosis.
  • Participants with a history of hypersensitivity to any ingredient of adalimumab.
  • Participants with demyelinating disease or a history of demyelinating disease.
  • Participants with congestive cardiac failure.

Exclusion

    Key Trial Info

    Start Date :

    December 1 2009

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    May 1 2014

    Estimated Enrollment :

    552 Patients enrolled

    Trial Details

    Trial ID

    NCT01163318

    Start Date

    December 1 2009

    End Date

    May 1 2014

    Last Update

    June 10 2015

    Active Locations (0)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 0 (0 locations)

    No Results Found

    We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

    Special Investigation of Humira® (Adalimumab) on Long-term Treatment in Patients With Rheumatoid Arthritis | DecenTrialz